Standout Papers

Adalimumab for induction of clinical remission in moderately to severely active ulcerative coliti... 2011 2026 2016 2021 662
  1. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial (2011)
    Walter Reinisch, William J. Sandborn et al. Gut

Immediate Impact

1 from Science/Nature 89 standout
Sub-graph 1 of 17

Citing Papers

Ulcerative colitis
2023 Standout
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
13 intermediate papers

Works of G. D’Haens being referenced

Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
2015
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
2011 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
G. D’Haens 955 832 367 34 1.2k
Satoshi Motoya 937 714 319 65 1.3k
Sara Onali 1028 694 493 65 1.4k
Judith Collins 1273 1013 350 18 1.6k
Edyta Zagórowicz 1152 929 524 28 1.6k
Jeroen M. Jansen 1219 923 351 48 1.4k
Elisabetta Colombo 631 513 382 43 1.1k
Esther García-Planella 1150 1031 459 64 1.5k
Satoru Umegae 1221 920 644 53 1.5k
Ian C. Lawrance 1074 643 417 24 1.6k
Maria Roussomoustakaki 555 417 556 27 1.1k

All Works

Loading papers...

Rankless by CCL
2026